ANRO
Price
$24.45
Change
+$1.51 (+6.59%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
804.7M
57 days until earnings call
Intraday BUY SELL Signals
KOD
Price
$37.05
Change
+$0.42 (+1.15%)
Updated
Jun 23, 04:59 PM (EDT)
Capitalization
2.29B
57 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ANRO vs KOD

ANRO vs KOD Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ANRO vs. KOD commentary
Jun 24, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANRO is a Buy and KOD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 24, 2026
Stock price -- (ANRO: $22.93 vs. KOD: $36.63)
Brand notoriety: ANRO and KOD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANRO: 113% vs. KOD: 93%
Market capitalization -- ANRO: $804.7M vs. KOD: $2.29B
ANRO [@Biotechnology] is valued at $804.7M. KOD’s [@Biotechnology] market capitalization is $2.29B. The market cap for tickers in the [@Biotechnology] industry ranges from $118.47B to $0. The average market capitalization across the [@Biotechnology] industry is $2B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANRO’s FA Score shows that 1 FA rating(s) are green whileKOD’s FA Score has 0 green FA rating(s).

  • ANRO’s FA Score: 1 green, 4 red.
  • KOD’s FA Score: 0 green, 5 red.
According to our system of comparison, ANRO is a better buy in the long-term than KOD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANRO’s TA Score shows that 6 TA indicator(s) are bullish while KOD’s TA Score has 5 bullish TA indicator(s).

  • ANRO’s TA Score: 6 bullish, 4 bearish.
  • KOD’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, ANRO is a better buy in the short-term than KOD.

Price Growth

ANRO (@Biotechnology) experienced а +8.31% price change this week, while KOD (@Biotechnology) price change was +7.55% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +5.89%. For the same industry, the average monthly price growth was +2.09%, and the average quarterly price growth was +1952.22%.

Reported Earning Dates

ANRO is expected to report earnings on Aug 19, 2026.

KOD is expected to report earnings on Aug 19, 2026.

Industries' Descriptions

@Biotechnology (+5.89% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
KOD($2.29B) has a higher market cap than ANRO($805M). KOD YTD gains are higher at: 31.009 vs. ANRO (28.820). ANRO has higher annual earnings (EBITDA): -71.22M vs. KOD (-204.74M). ANRO has more cash in the bank: 264M vs. KOD (170M). ANRO has less debt than KOD: ANRO (23.2M) vs KOD (56M). ANRO (0) and KOD (0) have equivalent revenues.
ANROKODANRO / KOD
Capitalization805M2.29B35%
EBITDA-71.22M-204.74M35%
Gain YTD28.82031.00993%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M170M155%
Total Debt23.2M56M41%
FUNDAMENTALS RATINGS
KOD: Fundamental Ratings
KOD
OUTLOOK RATING
1..100
38
VALUATION
overvalued / fair valued / undervalued
1..100
65
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANROKOD
RSI
ODDS (%)
Bullish Trend 2 days ago
80%
Bullish Trend 2 days ago
85%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
77%
Bearish Trend 2 days ago
79%
Momentum
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
86%
MACD
ODDS (%)
Bullish Trend 2 days ago
73%
Bullish Trend 2 days ago
85%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
84%
Declines
ODDS (%)
Bearish Trend 8 days ago
84%
Bearish Trend 16 days ago
87%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
85%
Bullish Trend 2 days ago
83%
Aroon
ODDS (%)
Bearish Trend 2 days ago
72%
Bearish Trend 2 days ago
88%
View a ticker or compare two or three
Interact to see
Advertisement
ANRO
Daily Signal:
Gain/Loss:
KOD
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ADCIX24.51N/A
N/A
American Century Disciplined Growth I
MXNSX23.83N/A
N/A
Empower S&P SmallCap 600® Index L
SCJCX7.85N/A
N/A
Steward Covered Call Income C
PZHEX13.98N/A
N/A
T. Rowe Price Hedged Equity Z
FESGX79.82-0.59
-0.73%
First Eagle Global C